scholarly journals 0389 Prevalent Insomnia Symptoms and Need for an Intervention Among Oncology Nurses

SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A149-A149
Author(s):  
S Lee ◽  
T F Vigoureux ◽  
B D Gonzalez ◽  
B J Small

Abstract Introduction Insomnia is prevalent in the working population. Nurses may be particularly vulnerable to insomnia due to demands with shift work, limited recovery between shifts, lack of control over their work, and stress associated with proximity to life-threatening health conditions. Insomnia in nurses is a significant public health burden, because it can lead to degraded quality of patient care. This study examined the prevalence of insomnia symptoms among oncology nurses and the need for an intervention to improve insomnia symptoms. Methods Participants were 62 nurses working full-time at a cancer hospital (Mage=35.26±11.69). Participants were asked about their (1) main sleep-related complaint, (2) willingness to participate in a sleep-focused intervention, (3) preferred delivery forms of the intervention (i.e., group-based, online, and/or one-on-one), and (4) preference for content to include in the intervention (e.g., sleep hygiene education, mindfulness, cognitive-behavioral therapy). We used content analysis to analyze open-ended responses as well as descriptive statistics to summarize data. Results Most (74%) reported difficulty falling or staying asleep or not feeling rested upon awakening as their primary or secondary sleep concerns. Nearly all nurses (95%) expressed interest in participating in a future sleep-focused intervention. In terms of preferred delivery forms of the intervention, an online intervention was most preferred (56%), followed by group meetings at the workplace (50%), and one-on-one meetings at the clinic (29%). Mindfulness strategies were preferred by most nurses (73%), followed by cognitive-behavioral therapy (48%), and sleep hygiene education (34%). Conclusion Most oncology nurses report insomnia symptoms and the majority are interested in participating in an intervention to improve their insomnia symptoms either online or in group sessions at the workplace. The information obtained from this pilot study will serve as the basis for developing a future intervention to improve insomnia and overall sleep health in oncology nurses. Support This work was supported, in part, by the University of South Florida College of Behavioral & Community Sciences Internal Grant Program (PI: Lee, Grant No. 0134930).

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A144-A144
Author(s):  
Kathleen O’Hora ◽  
Beatriz Hernandez ◽  
Laura Lazzeroni ◽  
Jamie Zeitzer ◽  
Leah Friedman ◽  
...  

Abstract Introduction The prevalence of insomnia complaints in older adults is 30–48%, compared to 10–15% in the general population. Cognitive Behavioral Therapy for Insomnia (CBT-I) is a first-line, non-pharmacological sleep treatment for Insomnia. However, the relative impact of Behavioral (BT) and Cognitive (CT) components compared to that of CBT-I in older adults is unknown. Methods 128 older adults with insomnia were randomized to receive CBT-I, BT, or CT. Sleep diaries and the Insomnia Severity Index (ISI) were collected pre- and post-treatment and at a 6-month follow-up. We conducted split-plot linear mixed models with age and sex as covariates to assess within and between subject changes to test effects of group, time, and their interaction on ISI, sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), time in bed (TIB), sleep efficiency (SE), and percent of treatment responders (ISI decrease>7) and remitters (ISI<8). Effect size (d) was calculated by dividing the difference between means by the root-mean-squared error of the mixed effects model. Results All treatments lead to a significant improvement across outcome measures at post-treatment (p’s<0.001) and 6-months (p’s<0.01), with the exception of TIB, response, and remission. For TIB, there was a significant Group x Time interaction (p<0.001): while all treatments significantly reduced TIB post-treatment relative to baseline, CBT-I (p<0.001,d=-2.26) and BT (p<0.001,d=-1.59) performed significantly better than CT (p=0.003, d=-0.68). In contrast, at 6-months CBT-I (p<0.001,d=-1.16) performed significantly better at reducing TIB than CT (p=0.195,d=-0.24) or BT (p=0.023,d=-0.61) relative to baseline. There was also a non-significant trend for a Group x Time interaction for remission status (p=0.062). Whereas, the percentage of remitters within all groups post-treatment did not differ from chance (p>0.234), at 6 months, the percentage of remitters was significantly higher than chance in CBT-I (73.63%,p=0.026) and BT (78.08%,p=0.012), but not CT (47.85%,p=0.826). There were no other significant time or interaction effects (all p>0.05). Conclusion CBT-I and its components are effective in improving subjective insomnia symptoms in older adults. Evidence suggests CBT-I may be superior to either CT or BT alone in improving TIB in older adults. Support (if any) NIMHR01MH101468; MIRECC at VAPAHCS


2014 ◽  
Vol 15 (6) ◽  
pp. 701-707 ◽  
Author(s):  
Charles M. Morin ◽  
Simon Beaulieu-Bonneau ◽  
Hans Ivers ◽  
Annie Vallières ◽  
Bernard Guay ◽  
...  

2017 ◽  
Vol 9 (7) ◽  
pp. 35 ◽  
Author(s):  
Nooshin Basiri ◽  
Zahra Khayyer ◽  
Habib Hadianfard ◽  
Amirhossein Ghaderi

INTRODUCTION: The term sleep disorder refers to difficulty in initiating sleep, maintaining it or a relaxing sleep despite having enough time to sleep. Cognitive behavioral therapy is a non-drug multi-dimensional treatment that targets behavioral and cognitive factors of this disorder. Some pieces of research have shown that psychiatric and neurological disorders can be distinguished from distinct EEG patterns and neuro-feedback can be used to make a change in these patterns. This study aimed to compare the cognitive behavioral therapy and neuro-feedback in the treatment of insomnia.METHODS: The sample included people, who had already been diagnosed insomnia by a psychiatrist in Isfahan, Iran. Random sampling was employed to choose the participants. Pittsburg sleep quality index (PSQI) was used for the selection of the participants, too. The sample included 40 patients who were randomly selected and interviewed and then diagnostic tests performed on the PSQI, and then they were divided into 3 groups. Data were analyzed using ANOVA. Following the implementation of the independent effect of the treatment was significant and one-way ANOVA with post hoc test L.S.D were carried out on CBT and controls (p = 0.001), CBT, neuro-feedback therapy (p = 0.003), neuro-feedback treatment and control (p = 0.001).RESULTS: It was shown that there was a significant difference between the groups. Based on the descriptive statistics of the 2 abovementioned treatments, neuro-feedback therapy in first position and cognitive-behavioral therapy were most effective in the second position, and the control group showed the lowest efficiency.CONCLUSIONS: Both treatments were significantly effective, and so we can use both neuro-feedback and CBT for the treatment of insomnia.


2021 ◽  
Author(s):  
Helena R Bean ◽  
Justine Diggens ◽  
Maria Ftanou ◽  
Marliese Alexander ◽  
Lesley Stafford ◽  
...  

Study Objectives Sleep problems are common during chemotherapy for breast cancer (BC). We evaluated whether combined brief cognitive behavioral and bright light therapy (CBT+) is superior to treatment as usual with relaxation audio (TAU+) for insomnia symptoms and sleep efficiency (primary outcomes). Methods We randomized women receiving intravenous chemotherapy, stratified by tumor stage and insomnia severity index (ISI), to 6-weeks CBT+ or TAU+. CBT+ included one in-person session, one telephone call, seven emails, and 20 minutes bright light each morning. TAU+ comprised usual treatment and two emails with relaxation audio tracks. Patient-reported outcomes were assessed at baseline, midpoint (week 3), post (week 6) and 3-month follow-up. Results Women (N = 101) were randomly assigned to CBT+ or TAU+. Insomnia symptoms declined significantly more from baseline to post with CBT+ versus TAU+ (-5.06 vs -1.93, P = .009; effect size [ES] = .69). At 3-month follow-up, both groups had improved insomnia symptoms but did not differ (ES = .18, P = .56). CBT+ had higher patient-reported sleep efficiency than TAU+ after the start of intervention (P = .05) and more improvement in fatigue (ES = .59, P = .013) and daytime sleep-related impairment (ES = .61, P = .009) from baseline to post. Conclusions CBT+ had a clinically significant impact on insomnia and fatigue with moderate effect sizes. Results support offering cognitive behavioral therapy for insomnia and bright light therapy during chemotherapy for breast cancer to help manage sleep and fatigue. Clinical trial information: Registered with the Australian New Zealand Clinical Trials Registry (http://anzctr.org.au/), Registration Number: ACTRN12618001255279


SLEEP ◽  
2021 ◽  
Author(s):  
Helena R Bean ◽  
Justine Diggens ◽  
Maria Ftanou ◽  
Marliese Alexander ◽  
Lesley Stafford ◽  
...  

Abstract Study Objectives Sleep problems are common during chemotherapy for breast cancer (BC). We evaluated whether combined brief cognitive behavioral and bright light therapy (CBT-I+Light) is superior to treatment as usual with relaxation audio (TAU+) for insomnia symptoms and sleep efficiency (primary outcomes). Methods We randomized women receiving intravenous chemotherapy, stratified by tumor stage and insomnia severity index (ISI), to 6-weeks CBT-I+Light or TAU+. CBT-I+Light included one in-person session, one telephone call, seven emails, and 20 minutes bright light each morning. TAU+ comprised usual treatment and two emails with relaxation audio tracks. Patient-reported outcomes were assessed at baseline, midpoint (week 3), post (week 6) and 3-month follow-up. Results Women (N = 101) were randomly assigned to CBT-I+Light or TAU+. The CBT-I+Light group showed significantly greater improvement in insomnia symptoms than the TAU+ group (-5.06 vs -1.93, P = .009; between-group effect size [ES] = .69). At 3-month follow-up, both groups were lower than baseline but did not differ from each other (between-group ES = .18, P = .56). CBT-I+Light had higher patient-reported sleep efficiency than TAU+ immediately after the start of intervention (P = .05) and significantly greater improvement in fatigue (between-group ES = .59, P = .013) and daytime sleep-related impairment (between-group ES = .61, P = .009) than the TAU+ group. Conclusion CBT-I+Light had a clinically significant impact on insomnia and fatigue with moderate effect sizes. Results support offering cognitive behavioral therapy for insomnia and bright light therapy during chemotherapy for breast cancer to help manage sleep and fatigue.


2020 ◽  
Vol 77 (5) ◽  
pp. 484 ◽  
Author(s):  
Jennifer N. Felder ◽  
Elissa S. Epel ◽  
John Neuhaus ◽  
Andrew D. Krystal ◽  
Aric A. Prather

Sign in / Sign up

Export Citation Format

Share Document